RhettPKetterlingMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine & Pathology, Mayo Medical School

Dr. Ketterling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and ScienceFellowship, Clinical Cytogenetics, 2000 - 2002
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1996 - 2000
Howard Hughes Medical InstituteFellowship, Howard Hughes Medical Student Fellowship/Award, 1993 - 1996
Mayo Clinic College of MedicineClass of 1996
Luther CollegeB.A., Biology, Music: Vocal Performance, 1983 - 1987

MN State Medical License 1997 - 2025
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics

PubMed

406 citations
CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
A Tefferi, Terra L. Lasho, Christy Finke, Ryan A. Knudson, Rhett P. Ketterling
Leukemia. 2014-01-09
322 citations
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.
Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli
Journal of Clinical Oncology. 2017-12-09
17 citations
Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels.
Ayalew Tefferi, Maura Nicolosi, Domenico Penna, Mythri Mudireddy, Natasha Szuber
Blood Advances. 2018-08-14

Journal Articles

MPL-Mutated Essential Thrombocythemia: A Morphologic Reappraisal
Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated Myelofibrosis
Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Case Study Use of Mate-Pair Sequencing (MPseq) to Characterize a Complex Cryptic BCR/ABL1 Rearrangement Observed in a Newly Diagnosed Case of Chronic Myeloid Leukemia
Patricia T Greipp, Rhett P Ketterling, ScienceDirect
Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood
Join now to see all

Abstracts/Posters

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Stud...
Rhett P. Ketterling, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
Rhett P. Ketterling, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
Rhett P. Ketterling, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019